| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 1.000 | strong | 0.955 | 156 | 8 | 1987 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.975 | 81 | 2 | 1992 | 2019 | ||||||||
|
capicua transcriptional repressor | 0.523 | 0.692 | 1.00 |
|
group | 0.400 | None | 0.974 | 38 | 0 | 2009 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 2007 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2015 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.390 | None | 1.000 | 9 | 1 | 1985 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.380 | None | 1.000 | 12 | 0 | 1998 | 2018 | ||||||||
|
MDM4 regulator of p53 | 0.461 | 0.808 | 1.00 |
|
group | 0.380 | None | 1.000 | 8 | 0 | 2002 | 2017 | ||||||||
|
paired box 3 | 0.481 | 0.769 | 0.24 |
|
group | 0.380 | None | 1.000 | 8 | 0 | 1995 | 2018 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
group | 0.350 | None | 1.000 | 5 | 0 | 1989 | 2002 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 1990 | 2014 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 2015 | 2019 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 1998 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 4 | 0.457 | 0.808 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
mastermind like transcriptional coactivator 3 | 0.653 | 0.577 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ZNF667 antisense RNA 1 (head to head) | 0.691 | 0.308 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
EWS RNA binding protein 1 | 0.474 | 0.692 | 1.00 |
|
group | 0.200 | None | 0.976 | 85 | 0 | 1993 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.200 | None | 1.000 | 24 | 1 | 1995 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.200 | None | 1.000 | 18 | 0 | 2003 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
group | 0.200 | None | 1.000 | 14 | 0 | 2002 | 2019 |